Research on COVID and breastmilk
Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19
Alisa Fox1, Jessica Marino2, Fatima Amanat3, Florian Krammer3, Jennifer Hahn-Holbrook2, Susan Zolla-Pazner1, and Rebecca L. Powell1* 1Department of Medicine, Division of Infectious Diseases, and 3Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2Department of Psychology, University of California Merced, Merced, CA, USA
Maintaining safety and service provision in human milk banking: a call to action in response to the COVID-19 pandemic
COVID-19 – media
KK Shailaja has been hailed as the reason a state of 35 million people has only lost four to the virus. Here’s how the former teacher did it
Other research on formulas
Guidance for the Conduct and Reporting of Clinical Trials of Breast Milk Substitutes
This JAMA paper comes with supplementary data. It is the output from a global Delphi project which aims to protect breastfeeding when clinical trials of BMS are undertaken and provide criteria against which BMS trials can be judged.
A review of studies against these criteria is already ongoing by Bob Boyle’s team at Imperial.
An Australian/NZ on how people make up formula using instructions on tins https://www.sciencedirect.com/science/article/abs/pii/S0306919220300944 It includes this graphic that is being circulated (you can download a high resolution graphic at the link above). May be useful if we get a chance to comment on new Guidance Notes relating to labelling here in the UK.